Compare ZBAI & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBAI | HKPD |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Professional Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 10.6M |
| IPO Year | N/A | 2025 |
| Metric | ZBAI | HKPD |
|---|---|---|
| Price | $7.06 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.2K | ★ 35.0K |
| Earning Date | 03-12-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,200,000.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.55 | 21.72 |
| 52 Week Low | $4.83 | $0.68 |
| 52 Week High | $44.64 | $3.09 |
| Indicator | ZBAI | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 50.77 |
| Support Level | $6.88 | $0.76 |
| Resistance Level | $7.21 | $0.84 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 86.18 | 55.56 |
ATIF Holdings Ltd is a consulting company. It provides financial consulting services to small and medium-sized enterprises. It operates in one operating segment, which is the consulting service business. The company prominently generated revenues from consulting services to its clients. Geographically, the maximum revenue is derived from Hong Kong.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.